title: Ifenprodil attenuates the loss of parietal cortical parvalbumin immunoreactivity after focal cerebral ischemia in the mouse.
authors.affiliation: Department of Pharmacology, University College Galway, Ireland.
authors.forename: S
authors.initials: S
authors.lastname: O'Mahony
authors.forename: D
authors.initials: D
authors.lastname: Noonan
authors.forename: T
authors.initials: T
authors.lastname: Harkány
authors.forename: G I
authors.initials: GI
authors.lastname: De Jong
authors.forename: C
authors.initials: C
authors.lastname: Nyakas
authors.forename: B E
authors.initials: BE
authors.lastname: Leonard
mesh_terms: D000818:Animals; D001157:Arterial Occlusive Diseases / Q000188:drug therapy* / Q000378:metabolism; D002536:Cerebral Arteries / Q000187:drug effects / Q000378:metabolism; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D007150:Immunohistochemistry; D007395:Interneurons / Q000187:drug effects / Q000378:metabolism; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D051379:Mice; D010296:Parietal Lobe / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D010320:Parvalbumins / Q000378:metabolism*; D010880:Piperidines / Q000627:therapeutic use*
chemical_list: D018691:Excitatory Amino Acid Antagonists; D010320:Parvalbumins; D010880:Piperidines; C010739:ifenprodil